These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4655210)

  • 1. [Electrogastroenterographic control of the digestive effects of N-butyl hyoscine bromide].
    Martin A; Thillier JL; Moline J; Levet E; Quentin JC
    Therapie; 1972; 27(3):457-63. PubMed ID: 4655210
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hyoscine N-methyl sulfate in general gastro-enterology].
    Félix H; Badrouillard R
    J Med Lyon; 1969 Apr; 50(163):675-6 passim. PubMed ID: 5367023
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prediagnostic initial therapy of severe spastic pain conditions].
    Steger W
    Ther Ggw; 1978 Jul; 117(7):1111-8. PubMed ID: 675569
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinico-instrumental study of the therapeutic action of a new parasymaptholytic].
    Barbara L; Corinaldesi R; Macaluso G; Luchetta L; Ricci P; Casadio R; Miglioli M
    Clin Ter; 1976 Dec; 79(6):523-47. PubMed ID: 12909
    [No Abstract]   [Full Text] [Related]  

  • 5. [Combined antigastrin therapy in gastroduodenal diseases with CR 242 B (proglumide-buscapine)].
    La Banda Sañchez F
    Rev Esp Enferm Apar Dig; 1972 Jan; 36(2):231-40. PubMed ID: 5009968
    [No Abstract]   [Full Text] [Related]  

  • 6. [Controlled evaluation of a new synthetic spasmolytic (DA 3177) in/pathology of the digestive system].
    Battocchio F; Negri L; Tacchettti G
    Clin Ter; 1979 Jun; 89(6):601-10. PubMed ID: 397029
    [No Abstract]   [Full Text] [Related]  

  • 7. [Inhibition of gastric motility by rectal administration of hyoscine-N-butylbromide].
    Schmid E; Wagner T; Ritter U
    Arzneimittelforschung; 1971 Jun; 21(6):813-5. PubMed ID: 5109265
    [No Abstract]   [Full Text] [Related]  

  • 8. [Action of metopimazine on gastric motility. Double-blind study using external digestive electromyography].
    Bertrand J; Thillier JL
    Nouv Presse Med; 1975 Oct; 4(32):2319-20. PubMed ID: 1101213
    [No Abstract]   [Full Text] [Related]  

  • 9. [Digestive electrophoresis of N-butyl-hyoscine bromide].
    JANET J; TAJAN Y
    Sem Hop; 1959 May; 35(22):1661-3. PubMed ID: 13668591
    [No Abstract]   [Full Text] [Related]  

  • 10. [Testing of orally administered spasmolytics demonstrated by the effect of hyoscine-N-butylbromide on gastric motility].
    Schmid E; Bleichert A; Uberla K; Ritter U; Fehlhaber E
    Arzneimittelforschung; 1968 Nov; 18(11):1449-53. PubMed ID: 4885158
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the treatment of prolonged gastrointestinal paralysis].
    Kronberger L
    Dtsch Med J; 1969 Jul; 20(14):459-62. PubMed ID: 5808047
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of antispasmodic drugs on colonic motility. Part I: Laboratory study of the dog.
    Sasaki D; Kido A; Yoshida Y
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):333-7. PubMed ID: 6147311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical studies with the new antiemetic, metoclopramide.
    Tornetta FJ
    Anesth Analg; 1969; 48(2):198-204. PubMed ID: 4886548
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of hyoscine in upper gastrointestinal tract endoscopy.
    Steger AC; Galland RB; Murray JK; Spencer J
    Am J Gastroenterol; 1986 Jul; 81(7):615. PubMed ID: 3717131
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inhibition of small intestine motility by orally administered hyoscine-N-butylbromide].
    Schmid E; Bleichert A; Kitzing J; Ritter U
    Arzneimittelforschung; 1969 Jun; 19(6):998-9. PubMed ID: 5820047
    [No Abstract]   [Full Text] [Related]  

  • 16. [Controlled therapeutic trial of gastroenteric diseases with psychogenic interference].
    Malaguti P
    Minerva Med; 1970 Feb; 61(11):479-84. PubMed ID: 5416957
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of the drug HSp-2986 on antral motility, pyloric opening and gastric distensibility. Study with the fibrogastrocamera].
    Espejo Romero H; Castillo Rosales T
    G E N; 1972; 27(1):1-12. PubMed ID: 4632023
    [No Abstract]   [Full Text] [Related]  

  • 18. [Combination of N-butyl-bromide of hyoscine and phenyldimethylpyrazolone-methylmethane sodium sulfonate in labor].
    Guerra Cepeda A; Delgado Urdapilleta J; González Ramírez R; Moysen Solorio R
    Ginecol Obstet Mex; 1965; 20(117):585-92. PubMed ID: 5893418
    [No Abstract]   [Full Text] [Related]  

  • 19. Morphine, haloperidol and hyoscine N-butyl bromide combined in s.c. infusion solutions: compatibility and stability. Evaluation in terminal oncology patients.
    Negro S; Reyes R; Azuara ML; Sánchez Y; Barcia E
    Int J Pharm; 2006 Jan; 307(2):278-84. PubMed ID: 16297583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experience with a new benzodiazepines derivative: the RO-5-3350 in fundamental functional diseases of the gastrointestinal system].
    Herrerias Gutierrez JM
    Rev Esp Enferm Apar Dig; 1974 May; 43(3):343-8. PubMed ID: 4839158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.